Monday 01 December 2025
Internal Reference Number: FOI_8895
Date Request Received: 08/09/2025 00:00:00
Date Request Replied To: 17/09/2025 00:00:00
This response was sent via: By Email
Request Summary: Intra-vitreal injections or implants
Request Category: Researcher
| Question Number 1: I am analysing the usage of intra-vitreal injections or implants by the NHS. I would greatly appreciate if you could answer the following questions: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from May to August 2025: Aflibercept Bevacizumab Brolucizumab Dexamethasone Faricimab Fluocinolone acetonide Ranibizumab - Lucentis Ranibizumab - Biosimilar | |
| Answer To Question 1: Please see our response in the attached file. To accompany this answer to question 1 please also see the documents listed below:  13241 - FOI_8895 - Intra-vitreal injections or implants.xlsx | |
| Question Number 2: Please provide the number of injections/implants by eye condition for the four-month period from May to August 2025: Number of Injections/Implants: May to August 2025: Please see attached. | |
| Answer To Question 2: Please see our response in the attached file. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
